2021

1. Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group

   Leukemia and Lymphoma, Vol. 62, Núm. 12, pp. 2928-2938

2. The mutational landscape of acute myeloid leukaemia predicts responses and outcomes in elderly patients from the pethema-flugaza phase 3 clinical trial

   Cancers, Vol. 13, Núm. 10